These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 24213238)
1. Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis. Shishido H; Kawai N; Miyake K; Yamamoto Y; Nishiyama Y; Tamiya T Cancers (Basel); 2012 Mar; 4(1):244-56. PubMed ID: 24213238 [TBL] [Abstract][Full Text] [Related]
2. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957 [TBL] [Abstract][Full Text] [Related]
3. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of PET/CT with Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870 [TBL] [Abstract][Full Text] [Related]
5. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
6. [Use of 11F-fluorothymidine positron emission tomography in brain tumor]. Kawai N; Kagawa M; Miyake K; Nishiyama Y; Yamamoto Y; Shiraishi H; Ichikawa T; Tamiya T No Shinkei Geka; 2009 Jul; 37(7):657-64. PubMed ID: 19621774 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma. Jeong SY; Lim SM Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 4'-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging. Toyota Y; Miyake K; Kawai N; Hatakeyama T; Yamamoto Y; Toyohara J; Nishiyama Y; Tamiya T EJNMMI Res; 2015; 5():7. PubMed ID: 25853013 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas. Zhao F; Cui Y; Li M; Fu Z; Chen Z; Kong L; Yang G; Yu J Nucl Med Biol; 2014 Sep; 41(8):710-5. PubMed ID: 24929963 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Enslow MS; Zollinger LV; Morton KA; Butterfield RI; Kadrmas DJ; Christian PE; Boucher KM; Heilbrun ME; Jensen RL; Hoffman JM Clin Nucl Med; 2012 Sep; 37(9):854-61. PubMed ID: 22889774 [TBL] [Abstract][Full Text] [Related]
11. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944 [TBL] [Abstract][Full Text] [Related]
13. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Li DL; Xu YK; Wang QS; Wu HB; Li HS Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472 [TBL] [Abstract][Full Text] [Related]
14. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [TBL] [Abstract][Full Text] [Related]
16. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic usefulness of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography in recurrent brain tumor. Hong IK; Kim JH; Ra YS; Kwon DH; Oh SJ; Kim JS J Comput Assist Tomogr; 2011; 35(6):679-84. PubMed ID: 22082535 [TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
20. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Choi SJ; Kim JS; Kim JH; Oh SJ; Lee JG; Kim CJ; Ra YS; Yeo JS; Ryu JS; Moon DH Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):653-9. PubMed ID: 15711980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]